GB0106985D0 - Immunotherapeutic agent - Google Patents

Immunotherapeutic agent

Info

Publication number
GB0106985D0
GB0106985D0 GBGB0106985.5A GB0106985A GB0106985D0 GB 0106985 D0 GB0106985 D0 GB 0106985D0 GB 0106985 A GB0106985 A GB 0106985A GB 0106985 D0 GB0106985 D0 GB 0106985D0
Authority
GB
United Kingdom
Prior art keywords
immunotherapeutic agent
immunotherapeutic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0106985.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Silence Therapeutics PLC
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Priority to GBGB0106985.5A priority Critical patent/GB0106985D0/en
Publication of GB0106985D0 publication Critical patent/GB0106985D0/en
Priority to AU2002247836A priority patent/AU2002247836A1/en
Priority to PCT/GB2002/001323 priority patent/WO2002074330A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0106985.5A 2001-03-20 2001-03-20 Immunotherapeutic agent Ceased GB0106985D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0106985.5A GB0106985D0 (en) 2001-03-20 2001-03-20 Immunotherapeutic agent
AU2002247836A AU2002247836A1 (en) 2001-03-20 2002-03-20 Mycobacterrial estracts for treating autoimmune diseases
PCT/GB2002/001323 WO2002074330A2 (fr) 2001-03-20 2002-03-20 Agent d'immunotherapie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0106985.5A GB0106985D0 (en) 2001-03-20 2001-03-20 Immunotherapeutic agent

Publications (1)

Publication Number Publication Date
GB0106985D0 true GB0106985D0 (en) 2001-05-09

Family

ID=9911181

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0106985.5A Ceased GB0106985D0 (en) 2001-03-20 2001-03-20 Immunotherapeutic agent

Country Status (3)

Country Link
AU (1) AU2002247836A1 (fr)
GB (1) GB0106985D0 (fr)
WO (1) WO2002074330A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100992646B1 (ko) * 2003-07-09 2010-11-05 제이에스알 가부시끼가이샤 파장판
AU2007323134B2 (en) * 2006-11-23 2013-05-02 Cadila Pharmaceuticals Limited Poly-TLR antagonist
JP2010522155A (ja) * 2007-03-20 2010-07-01 カディラ ファーマシューティカルズ リミテッド Ｐ３８阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
EP0971733A1 (fr) * 1997-03-03 2000-01-19 Adcock Ingram Limited Composition renfermant un porteur et un composant lipidique membranaire mycobacterien purifie, son utilisation dans la prevention, le traitement et le diagnostic de maladies
JP2001519785A (ja) * 1997-04-02 2001-10-23 バイオニケ ライフ サイエンシーズ インコーポレイテッド 局所的障害および創傷の治療のための細菌細胞壁抽出物の使用

Also Published As

Publication number Publication date
AU2002247836A1 (en) 2002-10-03
WO2002074330A3 (fr) 2003-10-30
WO2002074330A2 (fr) 2002-09-26

Similar Documents

Publication Publication Date Title
DE60217162D1 (en) Tetrafluorethen-perfluorbutylethen-copolymer
DE60209787D1 (en) Flächiges implantat
DE50202400D1 (en) Baw-resonator
DE50201180D1 (en) Organopolysiloxan/polyharnstoff/polyurethan-blockcopolymere
DE60213216D1 (en) Metalloproteinaseinhibitoren
DE50209614D1 (en) 2-heteroarylcarbonsäureamide
DE50211022D1 (en) Heteroarylcarbonsäureamide
DE60214551D1 (en) Modulares airbagaufblassystem
DE60210819D1 (en) Pyrazolopyridazinderivate
DE60141364D1 (en) Polyphenylensulfidharzzusammensetzung
DE60141362D1 (en) Ösophagus-stoma-knopf
DE50202633D1 (en) Ophthalmoskop
AU2002360430A8 (en) 14-methyl-epothilones
DE60107296D1 (en) Kabelverstärkerverbindungsanordnung
DE60204140D1 (en) 5-ethyl-imidazotriazinone
DE60216319D1 (en) Heteroaryl-substituierte aminocyclohexan-derivate
DE50206483D1 (en) Displaymodul
DE50203686D1 (en) Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate
DE50201028D1 (en) Diarylgelbpigmentpraeparationen
DE50214962D1 (en) Heterocyclylarylsulfonamide
GB0106985D0 (en) Immunotherapeutic agent
AU2002313943A8 (en) Electromobile
GB0106987D0 (en) Immunotherapeuitic agent
GB0122162D0 (en) Agent
GB0106986D0 (en) Immunotherapeutic agent

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)